Implementing in-vitro diagnostic point-of-care tests in community health care: how can we make this work?
Turner PJ. et al, (2025), Br J Gen Pract, 75, 182 - 185
Diagnosis and Severity Assessment of COPD Using a Novel Fast-Response Capnometer and Interpretable Machine Learning.
Talker L. et al, (2024), COPD, 21
Favipiravir for COVID-19 in adults in the community in PRINCIPLE, an open-label, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hobbs FR. et al, (2024), Journal of Infection, 89
Stop antibiotics when you feel better? Opportunities, challenges and research directions
Borek AJ. et al, (2024), JAC-Antimicrobial Resistance, 6
Recurrent urinary tract infections and prophylactic antibiotic use in women: cross-sectional study.
Sanyaolu L. et al, (2024), Br J Gen Pract
Assessing the heterogeneity of ethnic categories for patient records in primary care
Hameed J. et al, (2024), The British journal of general practice : the journal of the Royal College of General Practitioners, 74
Trends in C reactive protein testing: a retrospective cohort study in paediatric ambulatory care settings.
Alkhmees M. et al, (2024), BMJ Open, 14
D-Mannose for Prevention of Recurrent Urinary Tract Infection Among Women: A Randomized Clinical Trial
Hayward G. et al, (2024), JAMA Internal Medicine, 184, 619 - 628
How do primary care clinicians approach the management of frailty? A qualitative interview study
Seeley A. et al, (2024), Age and Ageing, 53
Clinician and parent views on urine collection in precontinent children in the UK: a qualitative interview study.
Armengol M. et al, (2024), BMJ Open, 14
Erratum: Correction: Internet Tool to Support Self-Assessment and Self-Swabbing of Sore Throat: Development and Feasibility Study (Journal of medical Internet research (2023) 25 (e39791))
Lown M. et al, (2024), Journal of medical Internet research, 26
Viremia and HIV Drug Resistance Among People Receiving Dolutegravir Versus Efavirenz-Based First-Line Antiretroviral Therapy
Dorward J. et al, (2024), Journal of Acquired Immune Deficiency Syndromes, 95, E8 - E11
Ivermectin for COVID-19 in adults in the community (PRINCIPLE): An open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
Hayward G. et al, (2024), Journal of Infection, 88
Urine tenofovir and dried blood spot tenofovir diphosphate concentrations and viraemia in people taking efavirenz and dolutegravir-based antiretroviral therapy
Dorward J. et al, (2024), AIDS, 38, 697 - 702
General practitioners' perspectives on diagnostic tests for children: a qualitative interview study.
Thomas ET. et al, (2024), Br J Gen Pract
Diagnostic accuracy of a point-of-care antigen test for SARS-CoV-2 and influenza in a primary care population (RAPTOR-C19)
Fanshawe TR. et al, (2024), Clinical Microbiology and Infection, 30, 380 - 386
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Standing JF. et al, (2024), Nature communications, 15
Epidemiology and microbiology of recurrent UTI in women in the community in Oxfordshire, UK.
Vazquez-Montes MDLA. et al, (2024), JAC Antimicrob Resist, 6